Santander's Portuguese bank is not interested in buying Novo Banco, its CEO Pedro Castro Almeida said on Friday, as its ...
Amid the BBVA’s takeover bid for Banco Sabadell, the bank has decided to leave its current headquarters in Alicante—where it moved on October 5, 2017, at the beginning of the Catalan independence ...
Novo Banco's planned initial public offering would be beneficial for the Portuguese banking sector, Bank of Portugal Governor ...
NORTH OLMSTED, Ohio — Faucet and home fixture manufacturer Moen will close it's North Olmsted headquarters by sometime next year, its parent company confirmed Wednesday. In a statement to 3News ...
It is the largest study ever of the drug category—which includes Novo Nordisk’s GLP-1 treatments Ozempic and Wegovy and Eli Lilly’s dual-action GLP-1/GIP agonists Mounjaro and Zepbound.
Medicare added Novo Nordisk's Ozempic, Wegovy, and Rybelsus to its 2027 drug price negotiations list. This move could force Novo Nordisk to slash the costs of its top drugs. The company should ...
MADRID, Jan 21 (Reuters) - Spain's Banco Sabadell (SABE.MC), opens new tab is planning to hold an extraordinary board meeting shortly to move its headquarters back to Catalonia, two sources with ...
SDI qualified for $15 million in state grants since then: $10 million as an incentive to make Auburn Hills its North American headquarters and $5 million for an expansion. These state grants are ...
Bernard Arnault is once again in charge of Europe's most valuable company. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...
Novo Nordisk has commenced the STEP UP and STEP UP T2D trials to explore the efficacy of semaglutide 7.2mg. Credit: © 2025 Novo Nordisk A/S. Novo Nordisk’s high ...
Bagsværd, Denmark, 17 January 2025 – Novo Nordisk today announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial ...
Novo Nordisk is facing serious pressure from a powerful adversary. It still has plenty of leeway to penetrate its target market, for now. Investors should keep a close eye on this company. But it ...